Solid-State-NMR-Structure-Based Inhibitor Design to Achieve Selective Inhibition of the Parallel-in-Register β-Sheet versus Antiparallel Iowa Mutant β-Amyloid Fibrils.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Physical Chemistry B

• Publication date

  2017-05-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jpcb.7b02953PMID 28535056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid beta oligomers induce neuronal elasticity changes in age-dependent manner: a force spectroscopy study on living hippocampal neurons

  2016cited by this paper
• Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils.

  2016cited by this paper
• Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis*

  2016cited by this paper
• Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril

  2016cited by this paper
• Structural Variation in Amyloid-β Fibrils from Alzheimer’s Disease Clinical Subtypes

  2016cited by this paper
• Fibrillation of β amyloid peptides in the presence of phospholipid bilayers and the consequent membrane disruption.

  2015cited by this paper
• Modeling an in-register, parallel "iowa" aβ fibril structure using solid-state NMR data from labeled samples with rosetta.

  2015cited by this paper
• Amyloid polymorphism: structural basis and neurobiological relevance.

  2015cited by this paper
• Interactions between misfolded protein oligomers and membranes: A central topic in neurodegenerative diseases?

  2015cited by this paper
• Photophysical study of Thioflavin T as fluorescence marker of amyloid fibrils

  2014cited by this paper
• Structural evolution and membrane interactions of Alzheimer's amyloid‐beta peptide oligomers: New knowledge from single‐molecule fluorescence studies

  2014cited by this paper
• Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.

  2013cited by this paper
• Tranilast binds to aβ monomers and promotes aβ fibrillation.

  2013cited by this paper
• Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis' still alive?

  2013cited by this paper
• Rational design of potent domain antibody inhibitors of amyloid fibril assembly

  2012cited by this paper
• Side-chain dynamics reveals transient association of Aβ(1-40) monomers with amyloid fibers.

  2012cited by this paper
• A Novel Inhibitor of Amyloid β (Aβ) Peptide Aggregation

  2012cited by this paper
• Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils

  2012cited by this paper
• Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores.

  2012cited by this paper
• Analyzing Thioflavin T Binding to Amyloid Fibrils by an Equilibrium Microdialysis-Based Technique

  2012cited by this paper
• Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation

  2011cited by this paper
• The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

  2011cited by this paper
• Solid-state NMR studies of amyloid fibril structure.

  2011cited by this paper
• Structural evolution of Iowa mutant β-amyloid fibrils from polymorphic to homogeneous states under repeated seeded growth.

  2011cited by this paper
• Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils

  2010cited by this paper
• Principles governing oligomer formation in amyloidogenic peptides.

  2010cited by this paper
• Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils.

  2009cited by this paper
• Symmetry-based constant-time homonuclear dipolar recoupling in solid state NMR.

  2007cited by this paper
• Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid

  2007cited by this paper
• Molecular structure of amyloid fibrils: insights from solid-state NMR

  2006cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Sensitivity enhancement in structural measurements by solid state NMR through pulsed spin locking.

  2002cited by this paper
• Pathogenic effects of D23N Iowa mutant amyloid beta -protein.

  2001cited by this paper
• Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein*

  2001cited by this paper
• SIMPSON: a general simulation program for solid-state NMR spectroscopy.

  2000cited by this paper
• Structure-Based Design of N-Phenyl Phenoxazine Transthyretin Amyloid Fibril Inhibitors

  2000cited by this paper
• Candidate gene for the chromosome 1 familial Alzheimer's disease locus

  1995cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper

• Improving the inhibition of β-amyloid aggregation by withanolide and withanoside derivatives.

  2021cites this paper
• Molecular structure of a prevalent amyloid-β fibril polymorph from Alzheimer's disease brain tissue

  2020cites this paper
• Interactions of polyunsaturated fatty acids with amyloid peptides Aβ40 and Aβ42.

  2019cites this paper
• Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology

  2018cites this paper